About Stasys
Stasys is a Healthcare company based in Seattle (United States) founded in 2013 by Nathan White, Robert Barry, and Nate Sniadecki. Provider of POC device for analyzing blood clotting disorders and platelet dysfunction. Stasys has raised $2.85 million across 7 funding rounds from investors including HHS, DARPA and America’s Seed Fund. Its chief executive, as recorded, is Michael Rackley. Stasys offers products and services including Atlas Platelet Strength Test and Shear Force Technology. Its focus areas include Life Sciences, Hematology, In Vitro Diagnostics Tests and Coagulopathies. Its legal entity is Stasys Medical Corporation. Its competitors include Hemosonics, HemoSense and Exactus; 2 of its 3 listed competitors have raised funding.
Company details
Stasys was founded in 2013 in Seattle, United States, as a medical device company focused on hematology and trauma care. A point-of-care device is being developed to identify trauma-induced coagulopathy, which causes uncontrolled bleeding in patients. The technology analyzes clotting disorders and platelet function to support rapid diagnosis in clinical settings. Operations center on device innovation for emergency medical applications.
- Headquarters Seattle, United States
- Founders Nathan White, Robert Barry, Nate Sniadecki
- SectorsHealthcare
- Website stasysmedical.com
- Social LinkedIn X Facebook
- Legal Name Stasys Medical Corporation
- Total Equity Funding$2.85M (USD)
in 7 rounds
- Latest Funding Round$1.11M (USD), Grant
Apr 2021
- InvestorsHHS
& 6 more
Products & Services of Stasys
Stasys offers a comprehensive portfolio of products and services, including Atlas Platelet Strength Test and Shear Force Technology.
Rapid test measures platelet strength in blood to predict bleeding risks.
Enables reagent-free platelet activation for quick clinical assessments.
Funding Insights of Stasys
Stasys has successfully raised a total of $2.85M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $1.11 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.85M
- Total Rounds 7
- Last Round Grant — $1.11M
- First Round $149,993
(Jan 2014)
- Investors Count 7
All 7 funding rounds of Stasys with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $1.11M | Grant | – | – | |
| Jul 2019 | $224,945 | Grant | – | – | |
| Jun 2017 | $1.25M | Series A | – | – | – |
| Oct 2015 | $1.01M | Grant | – | – | |
| Feb 2015 | $1.6M | Series A | – | The W Fund | |
| Feb 2015 | $1.5M | Grant | – | – | |
| Jan 2014 | $149,993 | Grant | – | – |
7 investors in total: 7 institutional.
Investors in Stasys
Stasys has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, DARPA and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
| thewfund.com | ||||
Early-stage investments are made in Washington-based startups by WRF Capital. | wrfcapital.com | Seattle, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
| 1958 | darpa.mil | United States | ||
Gamespools is recognized as an online slot gaming platform. | lsdfa.org | Indonesia | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Stasys
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Stasys
6 people are tracked at Stasys (6 in leadership).
| Name | Role | Group |
|---|---|---|
Nathan White | Co-Founder | Leadership |
Robert Barry | Co-Founder & Chairman | Leadership |
Nate Sniadecki | Co-Founder | Leadership |
Michael Rackley | CEO | Leadership |
Brandon Ty Roy-Garland, MD | Chief Executive Officer | Leadership |
Lucas Ting | Director of Research & Development | Leadership |
Complete people profiles for Stasys
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Stasys
3 dated milestones of Stasys across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Stasys is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Grant, of $1.1M.
Competitors of Stasys
Stasys has 3 listed competitors in our database, 2 of them funded. They include Hemosonics, HemoSense and Exactus.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| hemosonics.com | 2004 | Charlottesville, United States | $24.92M | IVD for hemostasis characterization | ||
| hemosense.com | 1997 | San Jose, United States | $17.7M | Rapid Point-of-Care Coagulation analyzer | ||
| exactusinc.com | 2008 | Glen Allen, United States | 3 | POC diagnostics for fibrinolytic status assessment are developed. |
Detailed competitors of Stasys
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
3 companies that operate in the same segment as Stasys (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Stasys
Stasys was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Stasys is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Michael Rackley is the CEO of Stasys, as recorded in our data.
Stasys is a funded company, having raised a total of $2.85M across 7 funding rounds to date. The company's 1st funding round was a Grant of $149.99K, raised on Jan 2014.
Stasys was founded in 2013 in Seattle, United States, as a medical device company focused on hematology and trauma care. A point-of-care device is being developed to identify trauma-induced coagulopathy, which causes uncontrolled bleeding in patients. The technology analyzes clotting disorders and platelet function to support rapid diagnosis in clinical settings. Operations center on device innovation for emergency medical applications.
Stasys's top competitors include Hemosonics, Exactus and HemoSense.
Stasys offers Atlas Platelet Strength Test and Shear Force Technology.
Stasys has 7 investors. Key investors include HHS, DARPA, America’s Seed Fund, The W Fund, and WRF Capital.
Stasys operates through Stasys Medical Corporation.